P2.01-18 Differential Molecular Mechanisms Associated With Dramatic and Gradual Progression in NSCLC Patients With Intrathoracic Dissemination

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

JCSE01.22 Differential Molecular Mechanisms Associated With Dramatic and Gradual Progression in NSCLC Patients With Intrathoracic Dissemination

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PIG3 Promotes NSCLC Cell Mitotic Progression and Is Associated With Poor Prognosis of NSCLC Patients

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-127 Efficacy of Endostar Combined With Whole Brain Radiotherapy in Patients With NSCLC Brain Metastases

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-75 Study of Molecular Alterations in Cytological Smears by FISH in Patients With Advanced Non Small Cell Lung Carcinoma (NSCLC).

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-128 Low Positivity Rate in T790M Detection With ctDNA in NSCLC and Post EGFR-TKI Progression – Timing or Sensitivity?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-06 HSP72 Expression Associates With Survival in EGFR Mutated NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-21 Antigen Cascade Triggering Correlates With Prolonged Survival in Advanced NSCLC Patients Undergone PD-1 Blockade With Nivolumab.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy